Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pure Spectrum is a private U.S. cannabinoid wellness company that sells hemp-derived consumer health products under the Pure Spectrum CBD brand. The company focuses on THC-free, third-party-tested CBD and related phytocannabinoid products, including oils, gummies, softgels, mints, topicals, isolates, and pet formulations. Its business is centered on commercial manufacturing, branding, and direct-to-consumer e-commerce rather than prescription drug development. Pure Spectrum positions itself around science-backed wellness, athlete-oriented recovery, and quality-controlled phytocannabinoid formulations. The company appears to be an active commercial-stage cannabinoid wellness brand rather than a traditional biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pure Spectrum.